{'fraction_non_alphanumeric': 0.04426559356136821, 'fraction_numerical': 0.0, 'mean_word_length': 5.073170731707317, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Invasive Mold Infections After Chimeric Antigen Receptor-Modified T-cell Therapy: A Case Series, Review of the Literature, and Implications for Prophylaxis.

Data on invasive mold infections (IMIs) after chimeric antigen receptor T-cell (CAR-T) therapy are limited. We describe two patients with post-CAR-T-cell IMI (Fusarium, Mucorales) and review the published literature. We propose strategies to prevent IMIs in these patients, based on the IMI rate and presence of neutropenia or steroid use.